$PRSO
Peraso Inc.

2021 Q1 Form 10-Q Financial Statement

#000156459021027505 Filed on May 13, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $1.101M $1.260M
YoY Change -12.62% -64.2%
Cost Of Revenue $495.0K $530.0K
YoY Change -6.6% -60.86%
Gross Profit $843.0K $730.0K
YoY Change 15.48% -66.3%
Gross Profit Margin 76.57% 57.94%
Selling, General & Admin $1.071M $1.135M
YoY Change -5.64% 16.77%
% of Gross Profit 127.05% 155.48%
Research & Development $1.159M $961.0K
YoY Change 20.6% -16.65%
% of Gross Profit 137.49% 131.64%
Depreciation & Amortization $277.0K $41.00K
YoY Change 575.61% -43.06%
% of Gross Profit 32.86% 5.62%
Operating Expenses $4.094M $2.096M
YoY Change 95.32% -1.36%
Operating Profit -$3.612M -$1.366M
YoY Change 164.42% -3431.71%
Interest Expense -$30.00K $55.00K
YoY Change -154.55% 1.85%
% of Operating Profit
Other Income/Expense, Net $140.00 $16.00K
YoY Change -99.13% -30.43%
Pretax Income -$1.369M -$1.405M
YoY Change -2.56% -14150.0%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$4.157M -$1.405M
YoY Change 195.87% -14150.0%
Net Earnings / Revenue -377.57% -111.51%
Basic Earnings Per Share -$0.79 -$0.61
Diluted Earnings Per Share -$0.79 -$0.61
COMMON SHARES
Basic Shares Outstanding 5.241M 2.295M
Diluted Shares Outstanding 5.241M 2.295M

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $11.14M $5.600M
YoY Change 98.91% -11.11%
Cash & Equivalents $1.002M $5.640M
Short-Term Investments $1.610M $0.00
Other Short-Term Assets $534.0K $600.0K
YoY Change -11.0% -50.0%
Inventory $862.0K $1.100M
Prepaid Expenses
Receivables $375.0K $500.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $12.91M $7.900M
YoY Change 63.42% -25.28%
LONG-TERM ASSETS
Property, Plant & Equipment $359.0K $300.0K
YoY Change 19.67% 17.65%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $18.00K $0.00
YoY Change -100.0%
Total Long-Term Assets $377.0K $200.0K
YoY Change 88.5% -83.77%
TOTAL ASSETS
Total Short-Term Assets $12.91M $7.900M
Total Long-Term Assets $377.0K $200.0K
Total Assets $13.29M $8.100M
YoY Change 64.04% -31.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $81.00K $100.0K
YoY Change -19.0% -53.49%
Accrued Expenses $1.492M $1.400M
YoY Change 6.57% 27.5%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $434.0K
YoY Change
Total Short-Term Liabilities $2.022M $1.700M
YoY Change 18.94% -4.44%
LONG-TERM LIABILITIES
Long-Term Debt $145.0K $3.000M
YoY Change -95.17% 11.11%
Other Long-Term Liabilities $57.00K
YoY Change
Total Long-Term Liabilities $202.0K $3.000M
YoY Change -93.27% 7.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.022M $1.700M
Total Long-Term Liabilities $202.0K $3.000M
Total Liabilities $2.224M $4.640M
YoY Change -52.07% -0.06%
SHAREHOLDERS EQUITY
Retained Earnings -$244.0M -$239.9M
YoY Change 1.72% 1.69%
Common Stock $255.1M $243.4M
YoY Change 4.81% 0.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$6.901M $3.500M
YoY Change
Total Liabilities & Shareholders Equity $13.29M $8.140M
YoY Change 63.23% -31.05%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income -$4.157M -$1.405M
YoY Change 195.87% -14150.0%
Depreciation, Depletion And Amortization $277.0K $41.00K
YoY Change 575.61% -43.06%
Cash From Operating Activities -$1.013M -$708.0K
YoY Change 43.08% -2.48%
INVESTING ACTIVITIES
Capital Expenditures $2.000K $6.000K
YoY Change -66.67% -87.5%
Acquisitions
YoY Change
Other Investing Activities -$1.611M $300.0K
YoY Change -637.0% -119.23%
Cash From Investing Activities -$1.613M $294.0K
YoY Change -648.64% -118.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $6.800M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 552.0K 1.000K
YoY Change 55100.0% -200.0%
NET CHANGE
Cash From Operating Activities -1.013M -708.0K
Cash From Investing Activities -1.613M 294.0K
Cash From Financing Activities 552.0K 1.000K
Net Change In Cash -709.0K -413.0K
YoY Change 71.67% -82.34%
FREE CASH FLOW
Cash From Operating Activities -$1.013M -$708.0K
Capital Expenditures $2.000K $6.000K
Free Cash Flow -$1.015M -$714.0K
YoY Change 42.16% -7.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
57000
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
6000
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Liabilities
Liabilities
2224000
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
255046000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-243988000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
11063000
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13287000
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6134000
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6134000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
4836000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5000
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
84000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1013000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2000
CY2020Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
300000
CY2021Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1611000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1613000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
294000
CY2021Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
145000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-242619000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
2932000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8298000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1369000
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2021Q1 us-gaap Notes Payable Current
NotesPayableCurrent
434000
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
244000
CY2020Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
335000
CY2020Q4 us-gaap Liabilities
Liabilities
5366000
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
3000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
245548000
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1000
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3554000
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3554000
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
495000
CY2021Q1 us-gaap Gross Profit
GrossProfit
843000
CY2020Q1 us-gaap Gross Profit
GrossProfit
730000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1159000
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
961000
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1071000
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1135000
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
2096000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
16000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-1405000
CY2021Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-1000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1370000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1405000
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.28
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.61
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
35000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-111000
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4862000
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2295000
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2478000
CY2021Q1 mosy Stock Issued During Period Value Issuance Of Common Stock For Payment Of Accrued Interest
StockIssuedDuringPeriodValueIssuanceOfCommonStockForPaymentOfAccruedInterest
140000
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6817000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
68000
CY2020Q1 mosy Stock Issued During Period Value Stock Awards
StockIssuedDuringPeriodValueStockAwards
-1000
CY2020Q1 mosy Exercise Of Pre Funded Warrants Value
ExerciseOfPreFundedWarrantsValue
2000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
68000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
3500000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-1369000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-1405000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
18000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
41000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
68000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
68000
CY2021Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
30000
CY2020Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
55000
CY2021Q1 mosy Amortization Of Lease Right Of Use Asset
AmortizationOfLeaseRightOfUseAsset
49000
CY2020Q1 mosy Amortization Of Lease Right Of Use Asset
AmortizationOfLeaseRightOfUseAsset
47000
CY2021Q1 mosy Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-46000
CY2020Q1 mosy Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-50000
CY2021Q1 mosy Gain Loss On Settlement Of Convertible Notes Payable And Accrued Interest Net
GainLossOnSettlementOfConvertibleNotesPayableAndAccruedInterestNet
48000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-325000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-636000
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
263000
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
137000
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-134000
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
183000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-708000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6000
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6817000
CY2021Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2478461
CY2020Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2000
CY2021Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
3027000
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2000
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6266000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3640000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-413000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5889000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6053000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9529000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5640000
CY2020Q1 us-gaap Notes Issued1
NotesIssued1
112000
CY2021Q1 us-gaap Stock Issued1
StockIssued1
123000
CY2021Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
11140000
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:10pt;margin-bottom:0pt;text-indent:3.23%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses recognized during the reported period.&nbsp;&nbsp;Actual results could differ from those estimates.</p>
CY2021Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0
CY2021Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1000
CY2021Q1 mosy Allowance For Doubtful Accounts As Percentage Of Invoice Value For Problematic Customer Balances Maximum
AllowanceForDoubtfulAccountsAsPercentageOfInvoiceValueForProblematicCustomerBalancesMaximum
1.00
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
41000000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
41000000
CY2020 us-gaap Inventory Write Down
InventoryWriteDown
100000
CY2021Q1 us-gaap Inventory Write Down
InventoryWriteDown
0
CY2021Q1 us-gaap Revenue Performance Obligation Description Of Payment Terms
RevenuePerformanceObligationDescriptionOfPaymentTerms
The Company sells its products both directly to customers and through distributors generally under agreements with payment terms typically less than 60 days.
CY2021Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
0
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1063000
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2376000
CY2021Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
11139000
CY2021Q1 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q1 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2021Q1 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020Q1 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2021Q1 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2020Q1 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2021Q1 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2020Q1 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2021Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
654000
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
414000
CY2021Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
208000
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
185000
CY2021Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021Q1 mosy Number Of Measurements Of Profitability
NumberOfMeasurementsOfProfitability
1
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2021Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1487601
CY2021Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
5.00
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6800000
CY2021Q1 mosy Warrant To Purchase Of Common Stock
WarrantToPurchaseOfCommonStock
1032692
CY2021Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.40
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
42672
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
139964
mosy Gain Loss On Repayment Of Interest On Convertible Notes Payable
GainLossOnRepaymentOfInterestOnConvertibleNotesPayable
-16898
CY2021Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
613791000
CY2021Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.40
CY2021Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1473098
CY2021Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
1554173
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
64757
CY2021Q1 mosy Number Of Operating Leases Outstanding
NumberOfOperatingLeasesOutstanding
1
CY2021Q1 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.08
CY2021Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
53000000000
CY2021Q1 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
false
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
155000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
112000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
267000
CY2021Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
9000
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
258000
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
51000
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
56000

Files In Submission

Name View Source Status
0001564590-21-027505-index-headers.html Edgar Link pending
0001564590-21-027505-index.html Edgar Link pending
0001564590-21-027505.txt Edgar Link pending
0001564590-21-027505-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
mosy-10q_20210331.htm Edgar Link pending
mosy-20210331.xml Edgar Link completed
mosy-20210331.xsd Edgar Link pending
mosy-20210331_cal.xml Edgar Link unprocessable
mosy-20210331_def.xml Edgar Link unprocessable
mosy-20210331_lab.xml Edgar Link unprocessable
mosy-20210331_pre.xml Edgar Link unprocessable
mosy-ex1023_161.htm Edgar Link pending
mosy-ex311_6.htm Edgar Link pending
mosy-ex312_7.htm Edgar Link pending
mosy-ex321_8.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending